Fără conexiune la internet — se afișează versiunea salvată a paginii.

Insight Molecular…

USUSD
← Către Filtru
US:IMDXLSE:0KCC

Insight Molecular Diagnostics Inc. (LSE:0KCC) — Biotechnology: In Vitro & In Vivo Diagnostic Substances. Numărul de burse pe care se tranzacționează acțiunile companiei: 2. Pe această pagină — preț și grafic, dividende, principalii deținători și istoricul numărului de acțiuni.

Despre Companie

Site Web
imdxinc.com
Relații cu Investitorii
investors.imdxinc.com/
Sector
Health Care · Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sediu Central
NASHVILLE, United States
Director General
Joshua Riggs
Angajați
55
Listată din
29.01.2018 (LSE:0KCC)
Acțiuni în Circulație
32.72 mil. la 2026-08-03
Free Float
9.98 mil.
Capitalizare de Piață
110.28 mil. USD
Insideri
21%
Investitori Instituționali
56.5%
Industrie (SIC)
In Vitro & In Vivo Diagnostic Substances
FCF
−31.0 mil. USD
Datorie
1.87 mil. USD
numerar net
Câștiguri și FCF — pentru cele 12 luni până la 30.06.2026 (cel mai recent raport al companiei).
Descriere

Insight Molecular Diagnostics Inc. operates as a precision diagnostics company in the United States and internationally. The company develops and commercializes laboratory developed tests, kitted research use only tests, and kitted clinical tests. It is developing DetermaCNI, a blood-based monitoring tool that detects progression early after one cycle cancer treatment; and DetermaIO, a gene expression test that assesses the tumor microenvironment to predict response to immunotherapies. The company also offers GraftAssureCore test, a blood test designed to measure dd-cfDNA using a novel PCR-based measurement platform, for potential patient registrants; GraftAssureIQ, a transplant monitoring assay to measure the donor-derived cell-free DNA; and GraftAssureDx, a decentralized transplant monitoring levels of donor-derived cell-free DNA in plasma following kidney transplantation to aid in the assessment of the probability of allograft rejection at the time of testing in conjunction with standard clinical assessments. In addition, it provides testing services for biomarker discovery, assay design and development, clinical trial support, and various biomarker tests. The company has a collaboration agreement with Bio-Rad Laboratories, Inc. for the development and commercialization of research use only and in vitro diagnostics kitted transplant products using Bio-Rad's ddPCR instruments and reagents. The company was formerly known as OncoCyte Corporation and changed its name to Insight Molecular Diagnostics Inc. in June 2025. Insight Molecular Diagnostics Inc. was incorporated in 2009 and is based in Nashville, Tennessee.

Burse și Simboluri

BursăSimbolMonedăPrețTip
US USA StocksIMDX principalăUSD3.37 +2.74%acțiuni ordinare
LSE London Stock Exchange0KCC IOBUSD3.5317 +0.00%acțiuni ordinare

Preț pe 3 Luni

3M1Y3Y5Y
zi de creștere zi de scădereTreceți cu mouse-ul / atingeți o zi — prețurile de deschidere, închidere, maxim și minim
publicitate

Cei Mai Mari Acționari

DeținătorParticipațieAcțiuniData Raportului
Broadwood Capital, Inc.38.76%12.68 mil.2026-06-30
AWM Investment Company,…8.67%2.84 mil.2026-06-30
Vanguard Capital Managem…2.25%735 8472026-06-30
Pura Vida Investments, L…1.48%484 8452026-06-30
VANGUARD INDEX FUNDS-Van…1.45%475 4052026-06-30
Family Office Research L…1.13%368 8492026-06-30
Geode Capital Management…0.79%256 9032026-06-30
VANGUARD INDEX FUNDS-Van…0.76%248 0592026-06-30
JAMES ANDREA S. (Chief F…≈0.63%206 0602026-03-26
ARNO ANDREW (Director)≈0.56%184 4932026-06-11
FNY Investment Advisers,…0.56%182 5612026-06-30
Jane Street Group, LLC0.48%157 6822026-06-30
Blackrock Inc.0.46%150 5212026-06-30
Vanguard Fiduciary Trust…0.38%124 5762026-06-30
Fidelity Concord Street…0.33%108 0232026-07-31
LAST ANDREW J (Director)≈0.2%66 4522026-06-11
SILVERMAN LOUIS E (Direc…≈0.19%63 5072026-06-11
iShares Trust-iShares Mi…0.13%42 9712026-08-31
Fidelity Concord Street…0.12%38 6222026-07-31
RIGGS JOSHUA (Chief Exec…≈0.12%38 3652026-03-26
Fidelity Concord Street…0.11%36 1252026-07-31
Fidelity Concord Street…0.06%19 4922026-07-31
VANGUARD VALLEY FORGE FU…0.02%7 9272026-06-30
LIU JAMES YANG (Officer…≈0.01%3 7112026-03-26
VANGUARD Inst. INDEX Fd.…0.01%4 4562026-06-30
EQ Advisors Trust-1290 V…0.01%2 9022026-06-30
BROADWOOD PARTNERS, L.P.…——2026-04-27
SMITH PATRICK W. (Benefi…——2025-02-07